SCHEMBL559933

SCHEMBL559933

c1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6ccccc6)cc5)s4)s3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.59
MEN1 O00255 1/20 0.59
POLB P06746 1/20 0.59
KMT2A Q03164 1/20 0.59
HSD17B1 P14061 6/20 0.58
HSD17B2 P37059 5/20 0.58
NQO2 P16083 3/20 0.57
APP P05067 4/20 0.52
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52
CYP2E1 P05181 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2A6 P11509 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2B6 P20813 1/20 0.52
CYP2C19 P33261 1/20 0.52
ALDH1A1 P00352 2/20 0.50
HDAC1 Q13547 1/20 0.47
TAAR1 Q96RJ0 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13027924 1.00 RAB9A (0.59) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL13027921 1.00 RAB9A (0.59) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL2129425 1.00 RAB9A (0.59) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL7591626 1.00 RAB9A (0.59) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL12562754 1.00 RAB9A (0.59) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL14190049 0.97 MEN1 (0.61) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL12562751 0.97 MEN1 (0.61) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL560206 0.97 MEN1 (0.61) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL2240182 0.94 HSD17B1 (0.62) RAB9AMEN1POLBKMT2AHSD17B1
SCHEMBL2242666 0.94 HSD17B1 (0.62) RAB9AMEN1POLBKMT2AHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113540352-B Method for preparing organic crystal film by combining solution processing and vacuum evaporation 吉林大学 2023-05-23 CN claimed
CN-114400288-A Bipolar organic field effect transistor and preparation method thereof 上海应用技术大学 2022-04-26 CN claimed
US-20200316370-A1 DEVICE AND METHOD FOR NEUROSTIMULATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2020-10-08 US claimed
EP-3714493-A1 DEVICE AND METHOD FOR NEUROSTIMULATION Ramot at Tel-Aviv University Ltd. (IL) 2020-09-30 EP claimed
US-10656307-B2 Optical element FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2020-05-19 US claimed
US-20190179056-A1 Optical Element FRAUNHOFER GES FORSCHUNG (DE) 2019-06-13 US claimed
WO-2019102478-A1 DEVICE AND METHOD FOR NEUROSTIMULATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2019-05-31 WO claimed
US-10247856-B2 Method for producing an antireflection layer on a silicone surface and optical element Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2019-04-02 US claimed
EP-2966481-A1 METHOD FOR PRODUCING AN ANTIREFLECTION COATING ON A SILICONE SURFACE AND OPTICAL ELEMENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2016-01-13 EP claimed
US-20150309214-A1 Method for Producing an Antireflection Layer on a Silicone Surface and Optical Element Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2015-10-29 US claimed
EP-3871279-B1 MULTI-JUNCTION DEVICE PRODUCTION PROCESS OXFORD PHOTOVOLTAICS LTD (GB) 2026-04-01 EP disclosed
EP-3667751-B1 PASSIVATION OF METAL HALIDE PEROVSKITES UNIV OXFORD INNOVATION LTD (GB) 2026-03-11 EP disclosed
US-20250287769-A1 PHOTOVOLTAIC DEVICE OXFORD PHOTOVOLTAICS LIMITED (GB) 2025-09-11 US disclosed
US-12349530-B2 Photovoltaic device OXFORD PHOTOVOLTAICS LIMITED (GB) 2025-07-01 US disclosed
WO-2025119856-A1 PASSIVATIED A/M/X MATERIAL OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2025-06-12 WO disclosed
WO-2007086534-A1 ORGANIC FIELD EFFECT TRANSISTOR AND SEMICONDUCTOR DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-08-02 WO disclosed
WO-2007043493-A1 SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-04-19 WO disclosed
US-20070087487-A1 Semiconductor device and manufacturing method thereof SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-04-19 US disclosed
US-20020114973-A1 Molecular compound, luminous material using the same, and luminous element JAPAN CHEMICAL INNOVATION INSTITUTE (JP) 2002-08-22 US disclosed
US-6355365-B1 FOR USE IN ORGANIC ELECTRO LUMINESCENCE (EL) DEVICE; EFFICIENCY JAPAN CHEMICAL INNOVATION INSTITUTE (JP) 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020114973-A1 Molecular compound, luminous material using the same, and luminous element TYR, BRD4, NOTCH1 RAB9A 3031/4885MEN1 1513/4885POLB 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.